Esophagogastric junction (EGJ) adenocarcinoma survival improved recently, thanks to the use of multimodal treatments. Survival with surgery alone is instead still poor in all locally advanced and node-positive patients. Recurrence is still the main cause of death, and it is particularly high within 24 months. In this chapter we will discuss the long-term results with surgery alone and multimodal treatments in EGJ cancer patients and then the characteristics and types of recurrence.
Long-Term Results with Surgery Alone and Multimodal Treatments
Giacopuzzi, Simone;Treppiedi, Elio;Weindelmayer, Jacopo;de Manzoni, Giovanni
2017-01-01
Abstract
Esophagogastric junction (EGJ) adenocarcinoma survival improved recently, thanks to the use of multimodal treatments. Survival with surgery alone is instead still poor in all locally advanced and node-positive patients. Recurrence is still the main cause of death, and it is particularly high within 24 months. In this chapter we will discuss the long-term results with surgery alone and multimodal treatments in EGJ cancer patients and then the characteristics and types of recurrence.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Zanoni_LongTermEsoph_chapterBook_2017.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
248.93 kB
Formato
Adobe PDF
|
248.93 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
